COMMUNIQUÉS West-GlobeNewswire

PotNetwork Holdings, Inc.’s Diamond CBD Continues Surpassing $2 Million In Sales Per Month Practically Doubling Revenues Year Over Year

21/06/2018 - 12:00

Diamond CBD keeps breaking previous year’s records with May 2018 Sales FT LAUDERDALE, Fla., June 21, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--PotNetwork Holdings, Inc. (OTC Pink:POTN) is pleased to announce that its [...]

ViroGates’ initial public offering of new shares was 141% oversubscribed

21/06/2018 - 11:59

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN. This announcement does not constitute a prospectus. No one [...]

Enrollment of first patient in Phase II clinical trial for Gaucher disease

21/06/2018 - 09:17

Orphazyme A/S Company announcement No. 08/2018 Company Registration No. 32266355 Copenhagen, June 21, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare [...]

Shire Announces FDA Approval for Label Expansion of CINRYZE® for Prevention of Attacks in Pediatric HAE

21/06/2018 - 08:00

Shire Announces FDA Approval for Label Expansion of CINRYZE ® (C1 esterase inhibitor [human]) for Prevention of Attacks in Pediatric Hereditary Angioedema Patients CINRYZE is the first and only therapy indicated in the [...]

ThromboGenics Partners with Prevent Blindness at 2018 Focus on Eye Health National Summit in Washington DC

21/06/2018 - 08:00

Press release Leuven, Belgium, 21 June 2018 - ThromboGenics NV (Euronext Brussels: THR), a biopharma company focused on developing novel treatments for back of the eye diseases with an innovative pipeline in diabetic [...]

Bone Therapeutics SA: The preliminary documents for the Extraordinary General Shareholder Meeting on 9 July 2018 have been made available

21/06/2018 - 07:01

Regulated information The preliminary documents for the Extraordinary General Shareholder Meeting on 9 July 2018 have been made available Gosselies, Belgium, 21 June 2018, 7am CEST - BONE THERAPEUTICS (Euronext Brussels [...]

Bone Therapeutics SA : Mise à disposition des documents préparatoires à l'assemblée générale extraordinaire du 9 juillet 2018

21/06/2018 - 07:01

Information réglementée Mise à disposition des documents préparatoires à l'assemblée générale extraordinaire du 9 juillet 2018 Gosselies, Belgique, le 21 juin 2018, 7h00 CEST - BONE THERAPEUTICS (code Euronext Bruxelles [...]

Addex Shareholders Approve All Resolutions at Annual General Meeting

21/06/2018 - 07:01

Geneva, Switzerland, 21 June 2018 - Addex Therapeutics (SIX: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, announced today that its shareholders approved all the [...]

Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering

21/06/2018 - 03:37

BOSTON, June 20, 2018 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM), a biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of rare genetic [...]

AVROBIO, Inc. Announces Pricing of Initial Public Offering

21/06/2018 - 02:42

CAMBRIDGE, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc. (the “Company”), a Phase 2 clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral-based gene therapies to [...]

Xeris Pharmaceuticals Announces Pricing of Initial Public Offering of Common Stock

21/06/2018 - 00:31

CHICAGO, June 20, 2018 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (NASDAQ:XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and [...]

Two Publications Recognize NovuHealth as a Top Workplace in Minnesota

20/06/2018 - 23:25

The Star Tribune and Minneapolis/St. Paul Business Journal Both Include NovuHealth on Their Lists for 2018 MINNEAPOLIS, June 20, 2018 (GLOBE NEWSWIRE) -- NovuHealth , the healthcare industry’s leading consumer [...]

Oncobiologics Announces Conversion of Majority of Series A Convertible Preferred Stock

20/06/2018 - 22:21

CRANBURY, N.J., June 20, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (NASDAQ:ONS) (the “Company”) today announced that GMS Tenshi Holdings Pte. Limited (“GMS Tenshi”), the Company’s strategic business partner and [...]

Reata Announces Initiation of a Phase 1 Trial of RTA 1701, a Selective, Oral Allosteric Inhibitor of RORγt

20/06/2018 - 22:18

IRVING, Texas, June 20, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq:RETA), a clinical-stage biopharmaceutical company, today announced the initiation of a Phase 1 clinical trial of Reata’s RTA 1701, a [...]

Galapagos increases share capital through warrant exercises

20/06/2018 - 22:02

Mechelen, Belgium; 20 June 2018, 22.01 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 102,801 new ordinary [...]

Harvard Bioscience Subsidiary Data Sciences International Launches Two Telemetry Implants For Measuring Continuous Blood Glucose

20/06/2018 - 22:01

PhysioTel™ Digital M0G and M1G: Designed to Improve Animal Welfare in Large Animal Models ST. PAUL, Minn. and HOLLISTON, Mass., June 20, 2018 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary of [...]

MannKind to Host Institutional Investor and Analyst Meeting

20/06/2018 - 22:01

Renowned Endocrinology Expert Presenting Current Trends in Treatment and Management of Diabetes MannKind’s Chief Medical Officer Presenting New Afrezza ® Data Released at American Diabetes Association’s 78 th Scientific [...]

Oral semaglutide shows statistically significantly greater reductions in HbA1c and weight compared to Victoza® and sitagliptin in the PIONEER 4 and 7 trials

20/06/2018 - 21:22

Bagsværd, Denmark, 20 June 2018 - Novo Nordisk today announced the successful completion and headline results of the phase 3a trials PIONEER 4 comparing oral semaglutide as a treatment for adults with type 2 diabetes to [...]

RavenQuest BioMed Comments on Historic Senate Vote Passing Canada's Cannabis Act

20/06/2018 - 21:02

VANCOUVER, British Columbia, June 20, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE:RQB) (OTCQB:RVVQF) (Franfurt:1IT) (the “ Company ” or “ RavenQuest ”) comments on the historic vote in Canada's upper chamber on [...]